Suven Gets 2 Patents For Molecules Targeting CNS Disorder

New Delhi: Drug firm Suven Life Sciences has been granted two product patents, one each in India and Japan, for molecules to be developed for treatment of neuro-degenerative diseases.  The company has been granted "one product patent from India and one from Japan corresponding to the new chemical entities (NCEs) for treatment of disorders associated with neuro-degenerative diseases...," Suven Life Sciences said in a filing to BSE.  ...